Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Efficacy of Extended-release Injectable Naltrexone with Oral Naltrexone in Opiate Use Disorder
IRCT20170702034844N6Phase 3Completed
- Sponsor
- Nano Daru
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naltrexone in opioid use disorder (OUD) (2 arms), sponsored by Nano Daru. Started Jul 2020; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20170702034844N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170702034844N6.